Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case report


Aims and background. In recent years, targeted agents have replaced cytokine therapy as the standard of care for patients with metastatic renal cell carcinoma.
Methods and study design. We report a patient with multiple metastases from renal cell carcinoma treated with cytoreductive surgery and pazopanib.
Results and conclusions. The treatment resulted in an early and prolonged response, without toxicity.

Tumori 2014; 100(3): e83 - e86

Article Type: CASE REPORT



Elisa Biasco, Andrea Antonuzzo, Claudia Cianci, Lisa Derosa, Riccardo Marconcini, Azzurra Farnesi, Luca Galli

Article History

This article is available as full text PDF.

Download any of the following attachments:


Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.